SCHEMBL24784695

SCHEMBL24784695

FC(F)(F)c1cccc(N(P(c2ccccc2)c2ccccc2)P(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
MAPT P10636 4/20 0.41
RAB9A P51151 3/20 0.41
HTT P42858 1/20 0.41
IDH2 P48735 1/20 0.41
MAPK1 P28482 1/20 0.40
CETP P11597 2/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
SRD5A2 P31213 1/20 0.38
KCNK3 O14649 1/20 0.38
KIF11 P52732 2/20 0.38
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
GAA P10253 1/20 0.37
CES2 O00748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938874 0.81 TDP1 (0.38) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL6290803 0.76 ALDH1A1 (0.52) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL16755617 0.74 TDP1 (0.43) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL14416254 0.74 ALDH1A1 (0.50) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL27266904 0.74 TSHR (0.48) TSHRALDH1A1MEN1KMT2AMAPK1
SCHEMBL7592350 0.73 TSHR (0.52) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL15800804 0.73 TSHR (0.48) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL13367373 0.73 TSHR (0.48) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL29420182 0.73 MTNR1A (0.38) TSHRALDH1A1MEN1KMT2AMAPT
SCHEMBL6506855 0.71 CETP (0.49) TSHRALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11529622-B2 Catalyst systems SAUDI ARABIAN OIL COMPANY (SA) 2022-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11529622-B2 Catalyst systems CCRL2, CBR3, C1R TSHR 250/4885ALDH1A1 4648/4885MEN1 3121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.